CClinicalTrials.gg
CompletedNCT07296224SCANOBEUpdated Dec 22, 2025

Scannographic Predictive Factors of Change of Strategy During Metabolic Bariatric Surgery

An observational study in Obesity & Overweight, sponsored by Central Hospital, Nancy, France. Completed at 1 site in France. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-12-22.

Sponsored by Central Hospital, Nancy, France · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
288
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Background: Laparoscopic Roux-en-Y Gastric By-pass (LRYGB) is not always feasible due to intraoperative difficulties, necessitating a change during surgical procedure. Non-contrast abdominal CT scans is not recommended before bariatric surgery but could be informative and very few studies have evaluated the relevance of these scans. The primary objective was to identify CT scan criteria that could predict a change in the intraoperative therapeutic strategy during LRYGB. Secondary objectives included identifying clinical data associated with change of intraoperative strategy, the impact of surgeon's experience and evaluate postoperative complications.

Methods: The study was conducted in University Hospital of Nancy, France between October 2012 and December 2022. This retrospective matched-case-control study (1:3) compared patients with intraoperative change of strategy when LRYGB was initially planned (study group) versus matched patients who undergone LRYGB. Clinical, scannographic, surgical experience and postoperative complications data were collected in the two groups.

Read the detailed description

Obesity is a multifactorial condition involving behavioral, environmental and genetic factors . Possible treatments for obesity include nutritional, dietary and cognitive-behavioral management, as well as pharmacological therapies and metabolic bariatric surgery (MBS) . These treatments must be combined and tailored to each patient.

Before the performance of MBS only an esogastroduodenal endoscopy with systematic biopsies for Helicobacter pylori is currently recommended . In France, abdominal ultrasound is added for detecting vesicular lithiasis . According to the American Society for Metabolic and Bariatric Surgery abdominal ultrasound is indicated in patients presenting biliary tract symptoms or liver disease . Non-contrast abdominal CT scan is not an aspect of the initial assessment in Europe or in the United States . To our knowledge, only one MBS team evaluated the value of preoperative CT scans for identifying silent pathologies and concluded that the value of CT scans were minimal . In Nancy University Hospital, a preoperative non-contrast abdominal CT scan is proposed to all patients scheduled for MBS to screen for incidental lesions, hiatal hernia not visible in endoscopy and left liver hypertrophy.

In Nancy University Hospital, a Laparoscopic Roux-en-Y gastric bypass (LRYGB) is preferentially performed. Due to surgical difficulties, LRYGB is not always an option for treatment. In these cases, a change in the surgical procedure may be needed. In very difficult cases, the performance of any MBS may be impossible.

The investigator hypothesizes that preoperative scannographic features-especially increased left liver volume (LLV) -are predictive of intraoperative strategy change during LRYGB, and that this risk is further influenced by patient history and surgeon experience.

Design This was a retrospective, single-center, observational case-control study conducted between 1st October 2012 and 31st December 2022 at the University Hospital of Nancy.

Population All adult patients scheduled for LRYGB surgery at the Nancy University Hospital between 1st October 2012 and 31st December 2022 who underwent a change in intraoperative surgical strategy and who did not object to the collection of their data were identified. Patients who did not have a preoperative scan and those who were lost to follow-up within 6 months of surgery were excluded.

Based on surgical reports, a change in surgical strategy was defined as follows: patients who underwent laparoscopic sleeve gastrectomy, laparotomy Roux-en-Y gastric bypass or laparotomy sleeve gastrectomy instead of a LRYGB and patients who experienced an interruption of the procedure during LRYGB.

Each patient who had undergone a change in strategy was subsequently randomly matched with three 'controls' who were comparable in terms of age (within 5 years of each other), sex and body mass index (BMI). The controls were defined as patients with the same inclusion criteria as those patients in the 'change of strategy' group but who had undergone a LRYGB.

Collected data The clinical data that were collected included age, sex, weight, height, BMI, history of abdominal surgery, hypertension, diabetes, obstructive sleep apnoea syndrome, non-alcoholic fatty liver disease and dyslipidemia. Surgeon's experience reported as junior (≤100 cases of MBS) or senior (>100 cases of MBS), A unique radiologist who was unaware of the patient's details and surgical history analysed preoperative non-contrast abdominal CT scans and used Aw Server version 3.2. The preoperative scan criteria included parietal thickness, the peritoneal height/width ratio in axial section and the visceral perimeter at L1, the umbilical perimeter, the total psoas area (TPA) (mm2) at L3 and the LLV . The measurement of visceral perimeter, umbilical perimeter and total psoas area was performed using manual measurement. The measurement of the LLV was performed using semi-automatic measurement adjusted by the radiologist as necessary.

02

Conditions studied

  • Obesity & Overweight

Keywords

  • metabolic bariatric surgery
  • obesity
  • gastric bypass
  • sleeve
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 288 is above the median of 135 across 1,283 observational studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Central Hospital, Nancy, France is the lead sponsor of 778 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All adult patients scheduled for LRYGB surgery at the Nancy University Hospital between 1st October 2012 and 31st December 2022.

Patients with body mass index > 35 kg/m2 selected to underwent bariatric surgery by the medical and surgical team Patients with preoperative CT scan

Inclusion criteria

  • All adult patients scheduled for LRYGB surgery at the Nancy University Hospital between 1st October 2012 and 31st December 2022 who underwent a change in intraoperative surgical strategy
  • patient who did not object to the collection of their data.
  • patients over the age of 18

Exclusion criteria

Exclusion Criteria:

  • Patients who did not have a preoperative scan
  • patients who were lost to follow-up within 6 months of surgery
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
288 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients who underwent a change of surgical strategy

    patients who underwent an other surgical strategy than gastric by pass : laparoscopic sleeve gastrectomy, sleeve gastrectomy or gastric bypass by laparotomy, no metabolic bariatric surgery (procedure impossible to achieve)

  • control group

    patients who underwent laparoscopic gastric bypass. Each patient who had undergone a change in strategy was subsequently randomly matched with three 'controls' who were comparable in terms of age (within 5 years of each other), sex and body mass index (BMI). The controls were defined as patients with the same inclusion criteria as those patients in the 'change of strategy' group

06

What researchers measure

Primary outcomes

  1. left liver volume scannographic measure

    the Left Liver Volume (LLV) was measured on an abdominal CT scan by a raidologist

    Time frame: between 1st October 2012 and 31st December 2022

Secondary outcomes

  1. parietal thickness

    parietal thickness was measured on abdominal CT scan

    Time frame: between 1st October 2012 and 31st December 2022

  2. surgical experience, number of bariatric procedure done before the surgery studied (less than 100 procedures or more)

    Surgeon's experience reported as junior (≤100 cases of MBS) or senior (\>100 cases of MBS)

    Time frame: between 1st October 2012 and 31st December 2022

  3. Post operative morbidity

    Post-operative morbidity was evaluated using Clavien-Dindo classification ,180 days after surgery

    Time frame: between 1st October 2012 and 30st June 2023

07

Study locations

1 site
  • Centre Hospitalier Universitaire de Nancy
    Nancy, Grand Est 54000, France
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07296224
Lead sponsor
Central Hospital, Nancy, France
Responsible party
NOMINE-CRIQUI Claire (MD Head of endocrine surgery Unit, Central Hospital, Nancy, France) — Principal investigator
First posted
Dec 22, 2025
Start date
May 8, 2023
Primary completion
Jul 20, 2023
Completion
Sep 20, 2023
Last update
Dec 22, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion